TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Jinhai International Group Holdings Limited ( (HK:2225) ).
Jinhai Medical Technology Limited announced a strategic cooperation framework agreement with Medtronic Changzhou to promote real-time navigation and tracking spinal endoscope techniques in the PRC. This collaboration aims to develop advanced integrated solutions for spinal endoscopy, facilitate academic exchanges, and support clinical demonstrations and training. The agreement, initially set for one year, can be renewed, and formal agreements will be established as conditions mature, potentially enhancing Jinhai’s market position in the medical technology sector.
The most recent analyst rating on (HK:2225) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Jinhai International Group Holdings Limited stock, see the HK:2225 Stock Forecast page.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited, incorporated in the Cayman Islands, is an investment holding company with its shares listed on the Main Board of the Stock Exchange. The company, along with its subsidiaries, is involved in providing manpower outsourcing, dormitory services, IT services, construction ancillary services, and minimally invasive surgery solutions and medical products.
Average Trading Volume: 13,974,015
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.98B
See more insights into 2225 stock on TipRanks’ Stock Analysis page.